Choroideremia Clinical Trial
Official title:
A Phase 1/2 Safety Study in Subjects With CHM (Choroideremia) Gene Mutations Using an Adeno-Associated Virus Serotype 2 Vector to Deliver the Normal Human CHM Gene [AAV2-hCHM] to the Retina
This clinical study evaluates the safety and tolerability of AAV2-hCHM in participants with Choroideremia gene mutations.
The primary objective is to evaluate the safety and tolerability of subretinal administration of AAV2-hCHM, in an inter-subject group dose escalation in individuals with choroideremia, based on a comprehensive clinical monitoring plan. The secondary objectives are to define the dose of AAV2-hCHM required to achieve stable, or improved, visual function/functional vision and to assess development of immune responses to adeno-associated virus vector, serotype 2 (AAV2) and Rab escort protein 1 (REP-1). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02553135 -
Choroideremia Gene Therapy Clinical Trial
|
Phase 2 | |
Completed |
NCT01461213 -
Gene Therapy for Blindness Caused by Choroideremia
|
Phase 1/Phase 2 | |
Completed |
NCT03507686 -
A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111
|
Phase 2 | |
Recruiting |
NCT05258032 -
Structural and Functional Characterization of Rare Ocular Diseases
|
||
Recruiting |
NCT05282953 -
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05045703 -
The Dark-Adapted Retinal Function Response in Choroideremia (DARC) Study
|
N/A | |
Recruiting |
NCT01866371 -
High Resolution Retinal Imaging
|
||
Completed |
NCT01603576 -
Pilot Study of a Suprachoroidal Retinal Prosthesis
|
N/A | |
Enrolling by invitation |
NCT03584165 -
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
|
Phase 3 | |
Completed |
NCT03359551 -
Natural History of the Progression of Choroideremia Study
|
||
Recruiting |
NCT02435940 -
Inherited Retinal Degenerative Disease Registry
|
||
Active, not recruiting |
NCT04483440 -
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
|
Phase 1 | |
Completed |
NCT02670980 -
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy
|
N/A | |
Completed |
NCT02671539 -
THOR - Tübingen Choroideremia Gene Therapy Trial
|
Phase 2 | |
Completed |
NCT03406416 -
Study of a Suprachoroidal Retinal Prosthesis
|
N/A | |
Enrolling by invitation |
NCT05158049 -
Longitudinal Study of a Bionic Eye
|
||
Terminated |
NCT02994368 -
"Natural History" Study of Choroideremia
|
||
Terminated |
NCT01654562 -
The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00427180 -
IRIS PILOT - Extended Pilot Study With a Retinal Implant System
|
N/A | |
Completed |
NCT04750785 -
A Study to Assess Choroideremia (CHM) Health Outcomes
|